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Background 
 
Human parechoviruses (HPeVs) are widespread pathogens belonging to the Picornaviridae family and currently divided into 19 genotypes. HPeV 
infections are usually asymptomatic or associated with mild respiratory or gastrointestinal disease in children1; however, some genotypes, in 
particular HPeV type 3 (HPeV3), are capable of causing severe disease including sepsis-like illness especially in very young children (aged  less 
than 3 months). 
 
Objectives 
 
This study aimed to evaluate the prevalence and the risk of infection from HPeV and to describe the epidemiological and molecular characteristics 
of HPeV infections observed in children <6 months hospitalized with symptoms of sepsis-like illness. 
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Methods 
 
From January 1st, 2015, to December 31st, 2018, clinical samples (cerebrospinal fluid samples and/or blood samples) were collected for diagnosis 
of HPeV infection from 193 patients (median age: 21 days, range: 1 day - 6 months) hospitalized with symptoms of sepsis-like illness in two 
hospitals of Northern Italy. After RNA extraction, the presence of HPeV-RNA was identified by real-time RT-PCR (target 5’UTR) and a portion of 
HPeV VP3/VP1 junction (nt. 2159–2458) was sequenced for typing and molecular characterization3. 
Discussion and Conclusions 
 
This study confirmed the high prevalence of HPeV infection, particularly HPeV-3, in very young children hospitalized with symptoms of sepsis-like 
illness2. In our study, 14% of children <6 months tested HPeV-positive. Almost all were children <3 months; the risk of infection from HPeV in 
children <1 month was nearly 5-fold higher than that in older patients. As observed by others, HPeV was identified mainly during the summertime2-3. 
Including HPeV molecular detection in routine diagnostic tests would allow estimating the burden of HPeV infection and improving clinical 
management of pediatric patients. Further studies of molecular characterization and phylogenetic analyses of HPeV are needed to describe the 
evolution of these viruses and the association between the viral genotypes and the severity of disease or sequelae. 
Results 
 
1 - Prevalence of HPeVs in sepsis-like illness 
During the study period, 14% (27/193) of patients <6 months hospitalized with 
symptoms of sepsis-like illness tested HPeV-positive (Table 1). The highest 
prevalence of HPeV infection was identified in children <1 month and in those aged 
1-2 months being 16.5% (20/121) and 10.4% (5/48), respectively (Table 1). In children 
aged 2-3 months and in those >3 months HPeV prevalence was 7.1% (1/14) and 
10.0% (1/10), respectively (Table 1). Overall, 20/27 (74.1%) HPeV positive cases 
were <1 month (Fig. 1) and almost all (96.3%; 26/27) were <3 months. 59.2% (16/27) 
of HPeV positive cases were males (p>0.05). 
 
2 - Risk of infection from HPeVs by age-groups 
The risk of infection from HPeV in sepsis-like illness in children <1 month was nearly 
5-fold higher (OR=4.7; 95%CI: 1.9-11.5) than that observed in older patients.  
No difference in the risk of infection from HPeV was identified when the gender of 
patients was compared (OR=1.2; 95%CI: 0.8-1.4). 
 
3 - Temporal distribution of HPeVs 
As showed in figure 2, HPeV-positive cases were detected throughout the  
study period, mainly (12/27; 44.4%) during the summertime (from June  to August).  
 
4 – Molecular characterization of HPeV 
17 out of 27 (63%) HPeV positive samples were molecularly characterized; 
16 resulted HPeV-3 and 1 HPeV-5.  
 
 
Figure 1. 
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Table 1. 
Prevalence of 
HPeV detection 
in children with 
sepsis-like 
illness by age 
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0-1 121 20 16.5%
1-2 48 5 10.4%
2-3 14 1 7.1%
3-6 10 1 10.0%
Total 193 27 14.0%
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